Author | Owen A. O'Connor, MD, PhD | OncLive

Author | Owen A. O'Connor, MD, PhD


Dr. O'Connor on Targeting CD30 in DLBCL

September 10, 2015


Owen A. O'Connor, MD, PhD, professor of Medicine and Experiment Therapies, co-program director, Lymphoid Development and Malignancy Program, Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, discusses targeting CD30 expression in patients with diffuse large B-cell lymphoma.